Clinical trial
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy…
NCT00360971 · Radiation Therapy Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00360971 |
|---|---|
| Title | Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer |
| Official title | A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548; IND # 6370) for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Radiation Therapy With Concurrent Chemotherapy (Followed by… |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Mucositis, Pain, Radiation Toxicity |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | palifermin, cisplatin, placebo, neck dissection, radiation therapy |
| Enrollment | 21 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Aug 7, 2006 |
| Last update posted | Dec 26, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: